12 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/prime-time-a-branded-peyronies-disease-commercial-for-xiaflex-collagenase-clostridium-histolyticum-302527119.html
20 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/john-elway-teams-up-with-endo-to-share-update-on-dupuytrens-contracture-and-treatment-with-xiaflex-collagenase-clostridium-histolyticum-302310665.html
11 Oct 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125338
05 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/endo-announces-publication-of-xiaflex-collagenase-clostridium-histolyticum-data-analysis-in-peer-reviewed-urology-301841484.html
06 Dec 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/endo-to-cease-production-and-sale-of-qwo-collagenase-clostridium-histolyticum-aaes-301696374.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125338